Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Amplification-based expression data show bias towards long gene misregulation in synaptic disorders

ABSTRACT: Several recent studies have suggested that genes that are over 100 kb in length are particularly likely to be misregulated in neurological diseases associated with synaptic dysfunction, such as autism, Fragile X syndrome, and Rett syndrome. These length-dependent transcriptional changes seem to be modest, but, given the low sensitivity of high-throughput transcriptome profiling technology, the statistical significance of these results needs to be reevaluated. Here we show that transcriptional changes reflected in microarray and RNA-Sequencing benchmark datasets from the SEQC Consortium show a bias toward genes of greater length, even in the comparison of technical replicates. We hypothesized that PCR amplification, which is used in both microarray and RNA-Seq technologies, could be introducing this bias. We found that, when the fold-change values are small, PCR amplification in microarray and RNA-Seq technologies does produce a bias toward longer genes; we found no similar bias with nCounter technology, which is not based on PCR amplification. We provide an approach to more rigorously assess length-dependent changes that begins with comparing randomized control samples to estimate baseline gene length dependency and evaluate the statistical significance of gene length regulation.

ORGANISM(S): Homo sapiens

PROVIDER: GSE94073 | GEO | 2018/06/05

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Rett Syndrome in a dish model

Project description:Several recent studies have suggested that genes that are longer than 100 kb are more likely to be misregulated in neurological diseases associated with synaptic dysfunction, such as autism and Rett syndrome. These length-dependent transcriptional changes are modest in Mecp2 mutant samples, but, given the low sensitivity of high-throughput transcriptome profiling technology, the statistical significance of these results needs to be re-evaluated. Here, we show that the apparent length-dependent trends previously observed in MeCP2 microarray and RNA-Sequencing datasets, particularly in genes with low-fold changes, disappeared when compared to randomized control samples. As we found no similar bias with Nanostring technology, this bias seems to be particular to PCR amplification-based platforms. Transcriptional alterations with large fold-change values, however, can reveal an authentic long gene bias. Discriminating authentic from artefactual length-dependent trends requires establishing a baseline from randomized control samples.

2018-06-05 | GSE107399 | GEO

Cerebellar gene expression from Mecp2-null and WT mice [Nanostring data set]

2018-06-05 | GSE105046 | GEO

Cerebellar gene expression from Mecp2-null and WT mice [RNA-Seq data set]

2018-06-05 | GSE105045 | GEO

Homo sapiens

Project description:Small Sample Amplification Technologies

| PRJNA92259 | ENA

A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequence Quality Control consortium

Project description:We present primary results from the Sequencing Quality Control (SEQC) project, coordinated by the United States Food and Drug Administration. Examining Illumina HiSeq, Life Technologies SOLiD and Roche 454 platforms at multiple laboratory sites using reference RNA samples with built-in controls, we assess RNA sequencing (RNA-seq) performance for sequence discovery and differential expression profiling and compare it to microarray and quantitative PCR (qPCR) data using complementary metrics. At all sequencing depths, we discover unannotated exon-exon junctions, with >80% validated by qPCR. We find that measurements of relative expression are accurate and reproducible across sites and platforms if specific filters are used. In contrast, RNA-seq and microarrays do not provide accurate absolute measurements, and gene-specific biases are observed, for these and qPCR. Measurement performance depends on the platform and data analysis pipeline, and variation is large for transcriptlevel profiling. The complete SEQC data sets, comprising >100 billion reads (10Tb), provide unique resources for evaluating RNA-seq analyses for clinical and regulatory settings.

2014-08-08 | GSE56457 | GEO

A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequence Quality Control consortium

2014-08-08 | GSE47774 | GEO

Representative Illumina sequencing libraries upon T7-polymerase based amplification

Project description:This experiment highlights the extreme sequence bias generated by standard PCR amplication of sequencing libraries and decribes an adapted T7-polymerase based amplification method, which results in non-baised, representative libraries for Illumina sequencing

2010-10-28 | GSE23868 | GEO

Investigating PCR bias in TnSeq

Project description:As transposon sequencing (TnSeq) assays have become prolific in the microbiology field, it is of interest to scrutinize their potential drawbacks. TnSeq results are determined by counting transposon insertions following the PCR-based enrichment and subsequent deep sequencing of transposon insertions. Here we explore the possibility that PCR amplification of transposon insertions in a TnSeq library skews the results by introducing bias into the detection and/or enumeration of insertions. We compared the detection and frequency of mapped insertions when altering the number of PCR cycles in the enrichment step. In addition, we devised and validated a novel, PCR-free TnSeq method where the insertions are enriched via CRISPR/Cas9-targeted transposon cleavage and subsequent Oxford Nanopore sequencing. These PCR-based and PCR-free experiments demonstrate that, overall, PCR amplification does not significantly bias the results of the TnSeq assay insofar as insertions in the majority of genes represented in our library were similarly detected regardless of PCR cycle number and whether or not PCR amplification was employed. However, the detection of a small subset of genes which had been previously described as essential is indeed sensitive to the number of PCR cycles. We conclude that PCR-based enrichment of transposon insertions in a TnSeq assay is reliable but researchers interested in profiling essential genes should carefully weigh the number of amplification cycles employed in their library preparation protocols. In addition, we present a PCR-free TnSeq alternative that is comparable to traditional PCR-based methods although the latter remain superior owing to their accessibility and high sequencing depth.

2020-12-21 | GSE162988 | GEO

Investigating PCR bias in TnSeq

Project description:Investigating PCR bias in TnSeq

| PRJNA684144 | ENA

Comparison of RNA Amplification Techniques meeting the demands for the Expression Profiling of Clinical Cancer Samples

Project description:For microarray experiments starting with nanogram amounts of RNA it is essential to implement reproducible and powerful RNA amplification techniques. Available methods were mainly tested for reproducibility, only a few studies concentrated on potential amplification bias. We evaluated three amplification protocols, which are less time-consuming than the commonly used T7-RNA polymerase based in vitro transcription protocols and therefore may be more suitable for clinical use: Template Switching (TS)-PCR (SMART-PCR Kit, BD), Ribo-SPIA (single primer isothermal amplification, Oviation, Nugen) and a random primer-based PCR. Additionally a more sensitive labeling method, Dendrimer-labeling (Genisphere), was evaluated. All methods were compared to unamplified RNA labelled at reverse transcription. Hybridizations were carried out on a targeted two-colour oligonucleotide microarray. From our results we conclude that RNA amplification with TS-PCR is highly reproducible and results in a reliable representation of the starting RNA population. We then assessed whether RNA amplification of clinical breast and thyroid cancer samples with TS-PCR showed robust performance when altered cycle numbers or partially degraded RNA were used. According to our experiments TS-PCR proved to be a very reliable method for global RNA amplification, even when starting from partially degraded RNA down to a RNA Integrity Number (RIN) of 4.3. Keywords: microarray expression profiling, RNA amplification techniques, RNA integrity

2007-08-24 | GSE5588 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data